FindTrial
Sign In

Construction of multi-drug resistance and pan-drug resistance epidemiology and risk prediction model for patients in neuro-intensive care unit

Construction of multi-drug resistance and pan-drug resistance epidemiology and risk prediction model for patients in neuro-intensive care unit

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073321
Enrollment
Unknown
Registered
2023-07-06
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multidrug-resistant and pan-drug-resistant infections in neurocritically ill patients

Interventions

Case series:No

Sponsors

Northern Jiangsu People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. All patients are admitted to NICU; 2. Age = 18 years old; 3. Patients with at least one microbiological culture; 4. Upon admission, the patient's immediate family members or guardians sign the informed consent for this study.

Exclusion criteria

Exclusion criteria: 1. Infection with multi-drug resistant bacteria or pan-drug resistant bacteria occurred before admission to NICU; 2. Patients admitted to NICU for less than 24 hours; 3. Insufficient clinical data.

Design outcomes

Primary

MeasureTime frame
glasgow score;White blood cell count;red blood cell count;albumin count;Past medical history;—

Secondary

MeasureTime frame
hospital duration;hypertension;—

Countries

China

Contacts

Public ContactYuping Li

Neurosurgery Department of Clinical Medical College of Yangzhou University

yupingli@yzu.edu.cn+86 180 5106 2519

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026